img

Global Antibody Humanization Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Antibody Humanization Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Antibody Humanization market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Antibody Humanization market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Antibody Humanization in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Monoclonal Antibodies
Bispecific Antibodies
CDR Grafted Antibodies

Market Snapshot, By Application
HIV
SARS
RSV
Prion

Main Market Players Analyzed in this report, including
Yurogen Biosystems
PX'Therapeutics
Panorama Research
Oak BioSciences
Lonza
IONTAS
Accurus Biosciences

The study objectives of this report are
To study and analyze the global Antibody Humanization market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Antibody Humanization market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Antibody Humanization manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antibody Humanization market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Antibody Humanization submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antibody Humanization are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Antibody Humanization Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Antibody Humanization Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Antibody Humanization

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Antibody Humanization Sales Channel and Distributors Analysis
3.3.1 Antibody Humanization Sales Channel
3.3.2 Antibody Humanization Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in HIV
3.4.2 Major Buyers in SARS
3.5 Antibody Humanization Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Antibody Humanization Type Introduction
4.1.1 Monoclonal Antibodies
4.1.2 Bispecific Antibodies
4.1.3 CDR Grafted Antibodies
4.2 Global Antibody Humanization Sales by Type 2016-2021
4.3 Global Antibody Humanization Revenue by Type 2016-2021
4.4 Global Antibody Humanization Price by Type 2016-2021

5 Market Segment: by Application
5.1 Antibody Humanization Type Introduction
5.1.1 HIV
5.1.2 SARS
5.1.3 RSV
5.1.3 Prion
5.2 Global Antibody Humanization Sales by Application 2016-2021
5.3 Global Antibody Humanization Revenue by Application 2016-2021
5.4 Global Antibody Humanization Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Antibody Humanization Market by Region
6.1.1 Global Antibody Humanization Sales by Regions
6.1.2 Global Antibody Humanization Revenue by Regions
6.2 North America Antibody Humanization Market 2016-2021
6.3 Europe Antibody Humanization Market 2016-2021
6.4 Asia Pacific Antibody Humanization Market 2016-2021
6.5 South America Antibody Humanization Market 2016-2021
6.6 Middle East and Africa Antibody Humanization Market 2016-2021

7 North America
7.1 North America Antibody Humanization Market by Country 2016-2021
7.1.1 North America Antibody Humanization Sales by Country
7.1.2 North America Antibody Humanization Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Antibody Humanization Market by Country 2016-2021
8.1.1 Europe Antibody Humanization Sales by Country
8.1.2 Europe Antibody Humanization Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Antibody Humanization Market by Country 2016-2021
9.1.1 Asia Pacific Antibody Humanization Sales by Country
9.1.2 Asia Pacific Antibody Humanization Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Antibody Humanization Market by Country 2016-2021
10.1.1 South America Antibody Humanization Sales by Country
10.1.2 South America Antibody Humanization Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Antibody Humanization Market by Country 2016-2021
11.1.1 Middle East and Africa Antibody Humanization Sales by Country
11.1.2 Middle East and Africa Antibody Humanization Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Yurogen Biosystems
12.1.1 Yurogen Biosystems Company Information
12.1.2 Yurogen Biosystems Antibody Humanization Product Portfolio, Specification and Application
12.1.3 Yurogen Biosystems Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Yurogen Biosystems Key Development
12.2 PX'Therapeutics
12.2.1 PX'Therapeutics Company Information
12.2.2 PX'Therapeutics Antibody Humanization Product Portfolio, Specification and Application
12.2.3 PX'Therapeutics Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 PX'Therapeutics Key Development
12.3 Panorama Research
12.3.1 Panorama Research Company Information
12.3.2 Panorama Research Antibody Humanization Product Portfolio, Specification and Application
12.3.3 Panorama Research Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Panorama Research Key Development
12.4 Oak BioSciences
12.4.1 Oak BioSciences Company Information
12.4.2 Oak BioSciences Antibody Humanization Product Portfolio, Specification and Application
12.4.3 Oak BioSciences Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Oak BioSciences Key Development
12.5 Lonza
12.5.1 Lonza Company Information
12.5.2 Lonza Antibody Humanization Product Portfolio, Specification and Application
12.5.3 Lonza Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Lonza Key Development
12.6 IONTAS
12.6.1 IONTAS Company Information
12.6.2 IONTAS Antibody Humanization Product Portfolio, Specification and Application
12.6.3 IONTAS Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 IONTAS Key Development
12.7 Accurus Biosciences
12.7.1 Accurus Biosciences Company Information
12.7.2 Accurus Biosciences Antibody Humanization Product Portfolio, Specification and Application
12.7.3 Accurus Biosciences Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 IONTAS Key Development

13 Global Antibody Humanization Market Forecast by Region by Type and by Application
13.1 Global Antibody Humanization Sales, Revenue Forecast 2022-2027
13.2 Global Antibody Humanization Forecast by Regions
13.2.1 Global Antibody Humanization Sales Forecast by Region 2022-2027
13.2.2 Global Antibody Humanization Revenue Forecast by Region 2022-2027
13.3 Global Antibody Humanization Forecast by Type
13.3.1 Global Antibody Humanization Sales Forecast by Type 2022-2027
13.3.2 Global Antibody Humanization Revenue Forecast by Type 2022-2027
13.3.3 Global Antibody Humanization Price Forecast by Type 2022-2027
13.4 Global Antibody Humanization Forecast by Application
13.4.1 Global Antibody Humanization Sales Forecast by Application 2022-2027
13.4.2 Global Antibody Humanization Revenue Forecast by Application 2022-2027
13.4.3 Global Antibody Humanization Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Antibody Humanization Production Specifications
Table 2: Drivers in Antibody Humanization Market
Table 3: Restraints Antibody Humanization Market
Table 4: Opportunity in Antibody Humanization Market
Table 5: Comparion of Alternative and Antibody Humanization
Table 6: Antibody Humanization Raw Materials Key Suppliers List
Table 7: Antibody Humanization Distributors List
Table 8: Antibody Humanization Major Buyers in HIV
Table 9: Antibody Humanization Major Buyers in SARS
Table 10: Antibody Humanization Major Buyers in RSV
Table 11: Global Antibody Humanization Sales (K Units) by Type 2016-2021
Table 12: Global Antibody Humanization Sales Market Share by Type 2016-2021
Table 13: Global Antibody Humanization Revenue (Million USD) by Type 2016-2021
Table 14: Global Antibody Humanization Revenue Market Share by Type 2016-2021
Table 15: Global Antibody Humanization Price by Type 2016-2021
Table 16: Global Antibody Humanization Sales (K Units) by Application 2016-2021
Table 17: Global Antibody Humanization Sales Market Share by Application 2016-2021
Table 18: Global Antibody Humanization Revenue (Million USD) by Application 2016-2021
Table 19: Global Antibody Humanization Revenue Market Share by Application 2016-2021
Table 20: Global Antibody Humanization Price by Application 2016-2021
Table 21: Global Antibody Humanization Sales (K Units) by Region 2016-2021
Table 22: Global Antibody Humanization Sales Market Share by Region 2016-2021
Table 23: Global Antibody Humanization Revenue (Million USD) by Region 2016-2021
Table 24: Global Antibody Humanization Revenue Market Share by Region 2016-2021
Table 25: North America Antibody Humanization Sales (K Units) by Country 2016-2021
Table 26: North America Antibody Humanization Sales Market Share by Country 2016-2021
Table 27: North America Antibody Humanization Revenue (Million USD) by Country 2016-2021
Table 28: North America Antibody Humanization Revenue Market Share by Country 2016-2021)
Table 29: Europe Antibody Humanization Sales (K Units) by Country 2016-2021
Table 30: Europe Antibody Humanization Sales Market Share by Country 2016-2021
Table 31: Europe Antibody Humanization Revenue (Million USD) by Country 2016-2021
Table 32: Europe Antibody Humanization Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Antibody Humanization Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Antibody Humanization Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Antibody Humanization Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Antibody Humanization Revenue Market Share by Country 2016-2021)
Table 37: South America Antibody Humanization Sales (K Units) by Country 2016-2021
Table 38: South America Antibody Humanization Sales Market Share by Country 2016-2021
Table 39: South America Antibody Humanization Revenue (Million USD) by Country 2016-2021
Table 40: South America Antibody Humanization Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Antibody Humanization Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Antibody Humanization Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Antibody Humanization Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Antibody Humanization Revenue Market Share by Country 2016-2021)
Table 45 Yurogen Biosystems Company Information
Table 46 Yurogen Biosystems Antibody Humanization Product Portfolio, Specification and Application
Table 47 Yurogen Biosystems Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 PX'Therapeutics Company Information
Table 49 PX'Therapeutics Antibody Humanization Product Portfolio, Specification and Application
Table 50 PX'Therapeutics Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Panorama Research Company Information
Table 52 Panorama Research Antibody Humanization Product Portfolio, Specification and Application
Table 53 Panorama Research Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Oak BioSciences Company Information
Table 55 Oak BioSciences Antibody Humanization Product Portfolio, Specification and Application
Table 56 Oak BioSciences Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Lonza Company Information
Table 58 Lonza Antibody Humanization Product Portfolio, Specification and Application
Table 59 Lonza Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 IONTAS Company Information
Table 61 IONTAS Antibody Humanization Product Portfolio, Specification and Application
Table 62 IONTAS Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Accurus Biosciences Company Information
Table 64 Accurus Biosciences Antibody Humanization Product Portfolio, Specification and Application
Table 65 Accurus Biosciences Antibody Humanization Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Antibody Humanization Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Antibody Humanization Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Antibody Humanization Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Antibody Humanization Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Antibody Humanization Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Antibody Humanization Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Antibody Humanization Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Antibody Humanization Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Antibody Humanization Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Antibody Humanization Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Antibody Humanization Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Antibody Humanization Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Antibody Humanization Picture
Figure 2: Global Antibody Humanization Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Antibody Humanization Supply Chain Analysis
Figure 5: Antibody Humanization Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Monoclonal Antibodies
Figure 7: Product Picture of Bispecific Antibodies
Figure 8: Global Antibody Humanization Sales Market Share by Type, 2020
Figure 9: Global Antibody Humanization Revenue Market Share by Type, 2020
Figure 10: Antibody Humanization in HIV
Figure 11: Global Antibody Humanization Market: HIV 2016-2021
Figure 12: Antibody Humanization in SARS
Figure 13: Global Antibody Humanization Market: SARS 2016-2021
Figure 14: Global Antibody Humanization Sales Market Share by Application, 2020
Figure 15: Global Antibody Humanization Revenue Market Share by Application, 2020
Figure 16: Global Antibody Humanization Sales Market Share by Region 2016-2021
Figure 17: Global Antibody Humanization Revenue Market Share by Region 2016-2021
Figure 18: North America Antibody Humanization Sales (K Units) Status 2016-2021
Figure 19: North America Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 20: Europe Antibody Humanization Sales (K Units) Status 2016-2021
Figure 21: Europe Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Antibody Humanization Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 24: South America Antibody Humanization Sales (K Units) Status 2016-2021
Figure 25: South America Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Antibody Humanization Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 28: North America Antibody Humanization Sales Market Share by Country, 2020
Figure 29: North America Antibody Humanization Revenue Market Share by Country, 2020
Figure 30: United States Antibody Humanization Sales (K Units) Status 2016-2021
Figure 31: United States Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 32: Canada Antibody Humanization Sales (K Units) Status 2016-2021
Figure 33: Canada Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Antibody Humanization Sales (K Units) Status 2016-2021
Figure 35: Mexico Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 36: Europe Antibody Humanization Sales Market Share by Country, 2020
Figure 37: Europe Antibody Humanization Revenue Market Share by Country, 2020
Figure 38: Germany Antibody Humanization Sales (K Units) Status 2016-2021
Figure 39: Germany Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 40: France Antibody Humanization Sales (K Units) Status 2016-2021
Figure 41: France Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 42: UK Antibody Humanization Sales (K Units) Status 2016-2021
Figure 43: UK Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 44: Italy Antibody Humanization Sales (K Units) Status 2016-2021
Figure 45: Italy Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 46: Russia Antibody Humanization Sales (K Units) Status 2016-2021
Figure 46: Russia Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 47: Spain Antibody Humanization Sales (K Units) Status 2016-2021
Figure 48: Spain Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Antibody Humanization Sales Market Share by Country, 2020
Figure 50: Asia Pacific Antibody Humanization Revenue Market Share by Country, 2020
Figure 51: China Antibody Humanization Sales (K Units) Status 2016-2021
Figure 52: China Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 53: Japan Antibody Humanization Sales (K Units) Status 2016-2021
Figure 54: Japan Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 55: Korea Antibody Humanization Sales (K Units) Status 2016-2021
Figure 56: Korea Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Antibody Humanization Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 59: India Antibody Humanization Sales (K Units) Status 2016-2021
Figure 60: India Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 61: Australia Antibody Humanization Sales (K Units) Status 2016-2021
Figure 62: Australia Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 63: South America Antibody Humanization Sales Market Share by Country, 2020
Figure 64: South America Antibody Humanization Revenue Market Share by Country, 2020
Figure 65: Brazil Antibody Humanization Sales (K Units) Status 2016-2021
Figure 66: Brazil Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Antibody Humanization Sales (K Units) Status 2016-2021
Figure 68: Argentina Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Antibody Humanization Sales (K Units) Status 2016-2021
Figure 70: Colombia Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Antibody Humanization Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Antibody Humanization Revenue Market Share by Country, 2020
Figure 73: Turkey Antibody Humanization Sales (K Units) Status 2016-2021
Figure 74: Turkey Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Antibody Humanization Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Antibody Humanization Sales (K Units) Status 2016-2021
Figure 78: South Africa Antibody Humanization Revenue (Million USD) Status 2016-2021
Figure 79: Yurogen Biosystems Antibody Humanization Revenue Market Share Globally (2019-2021)
Figure 80: PX'Therapeutics Antibody Humanization Revenue Market Share Globally (2019-2021)
Figure 81: Panorama Research Antibody Humanization Revenue Market Share Globally (2019-2021)
Figure 82: Oak BioSciences Antibody Humanization Revenue Market Share Globally (2019-2021)
Figure 83: Lonza Antibody Humanization Revenue Market Share Globally (2019-2021)
Figure 84: IONTAS Antibody Humanization Revenue Market Share Globally (2019-2021)
Figure 85: Accurus Biosciences Antibody Humanization Revenue Market Share Globally (2019-2021)
Figure 89: Global Antibody Humanization Sales (K Units) Forecast (2022-2027)
Figure 90: Global Antibody Humanization Sales (K Units) Forecast (2022-2027)